Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anat Ashkenazi | F | 51 | 23 years | |
| Natasha Hernday | F | 52 | 13 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David M. Goldenberg | M | 85 | 36 years | |
| Michael Pehl | M | 60 | 2 years | |
| Susan Mahony | M | 60 | 18 years | |
| Harout Semerjian | M | 52 | - | |
| Vaughn Himes | M | 63 | 14 years | |
| Michael R. Garone | M | 66 | 3 years | |
| Randall L. Tobias | M | - | 12 years | |
| Douglas Williams | M | 66 | 3 years | |
| Nancy Simonian | M | 63 | 11 years | |
| Charles Baum | M | 65 | 1 years | |
| Darren Cline | M | 59 | 9 years | |
| Daniel Welch | M | 66 | 17 years | |
| James Kyle Bryan | M | - | - | |
| John McLaughlin | M | 72 | 9 years | |
| Ronak H. Shah | M | - | 2 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Christopher Boerner | M | 53 | 5 years | |
| Michael Astrue | M | 67 |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
| David Gryska | M | 68 | 18 years | |
| Jared M. Freedberg | M | 55 | 2 years | |
| Ken Bate | M | 73 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
| Robert A. Armitage | M | 75 | 13 years | |
| Webster Dunbar | M | 62 | 5 years | |
| Larry K. Benedict | M | 63 | 8 years | |
| Mallory Morales | F | 40 | 2 years | |
| Barbara Duncan | F | 59 | 1 years | |
| Win Bischoff | M | 81 | 14 years | |
| Charles Romp | M | - | 13 years | |
| Bing Li | M | 55 | 7 years | |
| Howard Levy | M | 70 | - | |
| Scott M. Stiffler | M | 54 | 7 years | |
| Timothy Garnett | M | 63 | 23 years | |
| Gian Reverberi | M | 58 | 5 years | |
| Richard Ernest Gilbert | M | - | 12 years | |
| Christian Bloomgren | M | - | 2 years | |
| Candace Brandt | F | - | 3 years | |
| Andrea Cranfill | F | - | 1 years | |
| Kimberly Marie Lein-Mathisen | F | 52 | 12 years | |
| Michael Andriole | M | 51 | 16 years | |
| Casey H. Logan | M | 52 | 6 years | |
| Scott Jacober | M | - | 18 years | |
| Jesper Gromada | M | - | 6 years | |
| Gabriel Luciano | M | - | 3 years | |
| Kimberly Mathisen, MBA | - | - | 12 years | |
| Allen Melemed | M | 60 | 22 years | |
| Ann Cunningham | F | 56 | 14 years | |
| Michael Overdorf | M | 54 | 19 years | |
| Lucas Montarce | M | 47 | - | |
| Peter Buhler | M | 54 | 2 years | |
| Jamie Dananberg | M | 66 | 12 years | |
| Maria Rivas | M | 60 | 11 years | |
| J. Ware | M | 71 | 17 years | |
| Michael Bumby | M | 60 | 11 years | |
| Meghann York Meenan | F | - | 1 years | |
| Mitchell Daniels | M | 48 | 1 years | |
| Michael Schröter | M | - | 2 years | |
| Mark Stejbach | M | 61 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 3 years |
| Bruce J. Seeley | M | 59 | 3 years | |
| William Ringo | M | 78 | 28 years | |
| William Chin | M | 76 | - | |
| Robert A. Hamm | M | 72 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 9 years |
| Victor E. Kotelianski | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
| Michael R. Slater | M | 77 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 10 years |
| David A. Broecker | M | 63 | 16 years | |
| David D. Pendergast | M | 76 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 years |
| Michael L. Eagle | M | 76 | 8 years | |
| Nelson M. Sims | M | 76 | 28 years | |
| Patricia A. Murphy | F | 65 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 3 years |
| Joseph M. Davie | M | 84 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 7 years |
| Burt Adelman | M | 71 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | - |
| George Myles Cordell Fisher | M | 84 | - | |
| Oranee T. Daniels | M | - | 3 years | |
| Larry Ellingson | M | 78 | 30 years | |
| Sarah P. Cecil | F | 72 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
| Dan Hartman | M | 62 | 4 years | |
| Frederick W. Ruebeck | M | 85 | 11 years | |
| Bryan Dunnivant | M | - | 3 years | |
| Scott Syphax | M | 60 | 2 years | |
| Patrick L. Bobbitt | M | - | 1 years | |
| Joseph B. Kleine | M | 60 | 11 years | |
| Timothy Garnett | - | - | 23 years | |
| Kapil Dhingra | M | 64 | 3 years | |
| Patricia A. Johnston | M | - | 4 years | |
| Vincent P. Mihalik | M | 73 | - | |
| Stéphane Bancel | M | 51 | 6 years | |
| Paul Truex | M | 55 | 3 years | |
| Robert Baughman | M | - | - | |
| Cary Pfeffer | M | 61 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 10 years |
| Jeff Krstich | M | 74 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 6 years |
| Scott Peterson | M | - | 4 years | |
| Mona L. Haynes | F | 66 |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 5 years |
| Lisa Guttman | F | - | 10 years | |
| Cezary Nadecki | M | - | 2 years | |
| Pamela A. Trail | M | 68 | 1 years | |
| Neal Fowler | M | 62 | 13 years | |
| Darren Braccia | M | - |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | 2 years |
| Martin F. Haslanger | M | - | 9 years | |
| Saul Factor | M | 65 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Morris Z. Rosenberg
- Personal Network
